Ion exchange resins Pharmaceutical applications and recent advancement
Keywords:
Ion exchange resins, taste maskingAbstract
Ion exchange resins are cross-linked water insoluble polymer-carrying, ionizable functional groups. IER have received considerable attention from pharmaceutical scientists because of their versatile properties as drug delivery vehicles. Research over the last few years has revealed that IER are equally suitable for drug delivery technologies, including controlled release, transdermal, nasal, topical and taste masking. The major drawback of sustained release of extended release or extended release is dose dumping, resulting in increased risk of toxicity. The use of IER has occupied an important place in the development of controlled- or sustained-release systems because of their better drug-retaining properties and prevention of dose dumping. Synthetic ion exchange resins have been used in pharmacy and medicine for taste masking or controlled release of drug. Drug resin complexation converts drug to amorphous form leading to improved drug dissolution. Several studies have reported the use of IER for drug delivery at the desired site of action. Sulfonated and carboxylic resins with a polystyrene backbone are most widely used in clinical medicine. Chemical deterioration of the resins is the result of several different processes. The FDA has the responsibility to define conditions under which safe food additives may be used in the production and preparation of foods and beverages.
References
Mantell CL, Ion exchangers. In Adsorption, McGraw-Hill, 1951, 185–216.
Adams BA and Holmes EL, (1935) Synthetic ionexchange resins, J. Soc. Chem. Ind. 54, 1935, 1T.
Chaudhary NC and Saunders L, Sustained release of drugs from ion-exchange resins. J. Pharm. Pharmaco, 8, 1956, 975–986.
Keating JW, Pharmaceutical preparations comprising cationexchange resin adsorption compounds and treatment therewith,1961, US Patent 2,990,332.
Hays, E.E. (1961) Pharmaceutical compositions containing a resin narcotic compound. US Patent 3,035,979.
Keating JW, Pharmaceutical preparations comprising phosphorous containing cation-exchange resins having a basic drug adsorbed thereon; and treatment therewith, 1964, US Patent 3,143,465.
Sharma BK, Instrumental methods of chemical analysis (Analytical chemistry), 23rd ed., Goel Publishing House, Delhi, 2004, c-123.
Borodkin S, Ion exchange resins and sustained release. In: Swarbrick J, Boylan JC, eds, Encyclopedia of Pharmaceutical Technology, Vol 8, New York: Marcel Dekker Inc, 1993, 203-216.
Notari RE, Biopharmaceutics and Clinical Pharmacokinetics, 4th ed., New York and Basel: Marcel Dekker Inc, 1987, 130-218.
Anand V, Kandarapu R, Garg S, Ion-exchange resins: carrying drug delivery forward, Drug Dev. Tech., Vol. 6, 2001, 17.
Jain NK, Advances in controlled and Novel drug Delivery, 1st ed., 2001, 290-306.
Borodkin, S, Polycarboxylic acid Ion exchane resin absorbates for taste coverage in chewable tablets, Journal of Pharmaceutical Science, 60(10), 1971, 1523-152.
Illum L, Nasal drug delivery compositions containing nicotine, 1996, US Patent 5,935,604.
Berge MS, Swarbrick J, Boylan, CJ, In Encyclopaedia of Pharamaceutical Technology, Vol. 13, Marcel Dekker, Inc., New York, 1996, 465.
Jones PH et al., J. Pharm. Sci., 58, 3, 1969, 337.
Bhalekar M, Avari JG, Jaiswal SB, Cation-exchanger in pharmaceutical formulation,, IJPS, 38 (4), 2004, 184-187.
Lu MF et al, A polymer carrier system for taste masking of macrolide antibiotics. Pharm. Res, 8, 1991, 706–712.
Borodkin, S, Yonker MH, Journal of pharmaceutical sciences, 59(40), 1971, 481.
Dr. Hughes L, New uses of ion exchange resin in pharmaceutical formulation; Rohm and Haas Research laboratory spring house, PA, USA.
Dr. Hughes L, Gehris A, A new method of characterizing the buccal dissolution of drug; Rohm and Haas Research laboratory spring house, PA, USA.
Pisal S, Zainnuddin R, Nalawade P, Mahadik K, Kadam S, Drug released property of Polyethylene – Glycol treated Ciprofloxacin – Indion 234 complexes, AAPS PharmSciTech, 5(4), 2004, 64.
Chaubal MV, Synthetic polymer based ion exchange resin, Drug delivery technology, 2006, 6-8.
Pisal S, Zainnuddin R, Nalawade R, Mahadik R, Kadam S, Molecular property of Ciprofloxacin – Indion 234 complexes, AAPS PharmSciTech., 5(4), 2004, 62.
Kanios D, Composition and methods to effect the release profile in the transdermal administration of
active agents, US patent 200 2000 4065, 2002.
Van Abbe NJ, Rees JT, J. Amer. Pharm.Asso.Sci., 47, 1998, 487.
Coletta V, Werfield RB, US Patent 3091574, 1963.
Rheenen V, Ralph P, Coating compositions containing ion exchange resin, US patent 6 815 466, 2004.
Siegel S, Journal of Pharmaceutical Science, 51, 1962, 1069.
Bennett A, Filtration and separation, 44 (6), 2007, 20-23.
Sriwongjanya M, Bodmeier R, Effect of ion exchange resins on the drug release from matrix tablets, Eur J Pharm Biopharm, 46, 1998, 321Y327.
Akkaramongkolporn P, Ngawhirunpat T, Dual ambroxal and chlorpheniramine resinate as an alternative carrier in concurrent resinate administration, Pharmazin, 58 2003, 195Y199.
Chaudhary NC, Saunders L, Sustained release of drugs from ion-exchange resins, J. Pharm. Pharmacol, 8, 1956, 975–986.
Amsel LP et al., Recent advances in sustained release technology using ion-exchange polymers, Pharm. Technol, 1984, 28–48.
Sayed UG, Bajaj AN, Oral controlled release bromhexine ion-exchange resinate suspension formulation, Indian Drugs, 37, 2000, 185–189.
Sprockel OL, Price JC, Evaluation of sustained release aqueous suspensions containing microencapsulated drug resin complexes, Drug Dev. Ind. Pharm., 15, 1989, 1275–1287.
Motycka S, Nairn JG, Preparation and evaluation of
microencapsulated ion-exchange resin beads, J. Pharm. Sci., 68, 1979, 211–215.
Motycka S, et al., Preparation and evaluation of microencapsulated and coated ion-exchange resin beads containing theophylline, J. Pharm. Sci., 74, 1985, 643–646.
Ichikawa H, et al., Use of ion-exchange resins to prepare 100 micrometer-sized microcapsules with prolonged drug release by the Wurster process, Int. J. Pharm., 216, 2001, 67–76.
Sriwongjanya M, Bodmeier R, Entrapment of drug loaded ion-exchange particles within polymeric microparticles, Int. J. Pharm., 158, 1999, 29–38.
Torres D, et al., Microencapsulation of ion-exchange resins by interfacial nylon polymerization, Int. J. Pharm., 59, 1990, 9–17.
Sanghavi NM, et al., Ion-exchange resins as matrices for controlled drug release, Indian Drugs, 26, 1988, 27–32.
Irwin WJ, Belaid KA, Alpar HO, Drug-delivery by ion-exchange. Part III. Interaction of ester pro-drugs of propranolol with cationic exchange resins, Drug Dev. Ind. Pharm., 13, 1987, 2047-2066.
Sriwongjanya M, Bodmeier R, Entrapment of drugloaded ion-exchange particles within polymer microparticles, Int. J. Pharm., 158, 1997, 29-38.
Cuna M, Jato JLV, Torres D, Controlled-release liquid suspensions based on ion-exchange particles entrapped within acrylic microcapsules, Int. J. Pharm., 199, 2000, 151-158.
Ichikawa H, Fujioka K, Adeyeye MC, Fukumori Y, Use of ion-exhange resins to prepare 100 mm-sized microcapsules with prolonged drug-release by the Wurster process, Int. J. Pharm., 216, 2001, 67-76.
Prasert, Akkaramong, Kalporn, Molecular property of Propranolol Hcl prepared in drug resin complex, Taylor francis, Volume 27.
Douglas, Stephen J, Drug adsorbates, US patent 5 219 563, 1993.
Sheumaker, Jerry L, Liquid prolonged released pharmaceutical formulation containing ionic constituent, United state patent 4,762,709, 1988.
Theodare F, Shults JD, Amphetamine review and update technical and pharmaceutical developments, American association of medical review office, XIV (4), 2003.
Yegnaswami R, Prolong released pharmaceutical preparations, United state patent 4,221,778, 1980.
Kurowski M, et al., The efficacy and relative bioavailability of diclofenac resinate in rheumatoid arthritis patients, Int. J. Clin. Pharmacol. Ther. 32, 1994, 433–440.
Amsel LP, et al., Recent advances in sustained release technology using ion-exchange polymers, Pharm. Technol, 1984, 28–48.
Sayed UG, Bajaj AN, Oral controlled release bromhexine ion-exchange resinate suspension formulation, Indian Drugs, 37, 2000, 185–189.
Hussain MA, et al., Hollow fibres as an oral sustained release delivery system. Pharm. Res., 6, 1989, 49–52.
Fell TJ, et al., Prolonged gastric retention using floating dosage forms, Pharm. Technol. March, 2000, 82–88.
Atyabi F, et al., Controlled drug release from coated floating ion-exchange resin beads, J. Control. Release, 42, 1996, 25–28.
Atyabi F, et al., In vivo evaluation of a novel gastric retentive formulation based on ion-exchange resins, J. Control. Release, 42, 1996, 105–113.
Jackson SJ, et al., Comparative scintigraphic assessment of the intragastric distribution and residence of Cholestyramine, Carbopol 934P and Sucralfate, Int. J. Pharm., 212, 2001, 55–62.
Irwin WJ, et al., Drug delivery by ion-exchange Part VII: Release of acidic drugs from aniKo, H. and Royer, M.E., In vitro binding of drugs to Colestipol hydrochloride, J. Pharm. Sci., 63, 1974, 1914–1920.
Burton S, et al., Intragastric distribution of ionexchange resins: a drug delivery system for the topical treatment of the gastric mucosa, J. Pharm. Phamacol. 47, 1995, 901–906.
Jones C, et al., In vitro release of cytotoxic agents from ion-exchange resins, J. Control. Release, 8, 1989, 251–257.
Chen, Y. et al., Evaluation of ion-exchange microspheres as carriers for the anticancer drug Doxorubicin: in-vitro studies, J. Pharm. Pharmacol, 44, 1991, 211–215.
Li VHK, et al., Influence of drug properties and routes of drug administration on the design of
sustained and controlled release systems. In Controlled Drug Delivery, Robinson JR, Lee VHL, eds, Marcel Dekker, 1987, 3-94.
Narisawa S, et al., An organic acid induced sigmoidal release system for oral controlled release preparations, Pharm. Res., 11, 1994, 111–116.
Narisawa, S, et al., An organic acid-induced sigmoidal release for oral controlled release preparations. 2. Permeability enhancement of Eudragit RS coating led by the physicochemical interactions with organic acid, J. Pharm. Sci., 85, 1994, 184–188.
Sawaya A, et al., Binding mechanism of Doxorubicin in ionexchange albumin microcapsules, J. Pharm. Sci., 76, 1987, 475–480.
Jani R, Gan O, Ali Y, Rodstrom R, Hancock S. Ion exchange resins for ophthalmic delivery, J. Ocul. Pharmacol., 10(1), 1994, 57-67.
Arnold, John D, Dihydrocodein and ibuprofen pharmaceutical compositions and method, US patent 4 571 400, 1986.
Illum, Lisbeth, Nasal drug delivery composition containing nicotine, United state patent 5,935,604, 1996.
Mizushima Y., et al., Medicaments for nasal administration, US Patent 5,942,242, 1996.
Conaghey OM, et al., Iontophoretically assisted in vitro membrane transport of nicotine from hydrogel containing ion-exchange resins, Int. J. Pharm., 170, 1998, 225–237.
Mehendal SN, Malshe VC, Eastern Pharmacist 3,1991.
Bellamy, Simon A, Hughes L, Method for the anhydrous loading of nicotine onto ion exchange resins, US patent 6 607 752, 2003.
Sriwangjanya M, Bodmeier R , Effect of ion exchange resin on drug released from matrix tablet, Pubmed, 46(3), 1998, 321-7.
Payne WW, Ion-exchange resins in clinical medicine, J. Pharm. Pharmacol., 8, 1956, 397–402.
Witzman JL, Drug used in the treatment of hyperlipoproteinemias, In Goodman & Gilman’s The Pharmacological Basis of Therapeutics, Hardman JG, Limbird LE, eds, 1996, 875–897.
Zagorodni AA, Kotova DL , Selemenev VF, Infrared spectroscopy of ion exchange resins: chemical deterioration of the resins, Reactive & Functional Polymers, 53, 2002,157–171.
P.E. Tulupov, Resistance of Ion Exchange Materials, Khimia, and elevated temperature results in degradation Moscow, 1984.
Jay A, Miers JR, Independence Mall West, Rohm and Haas Company, Philadelphia, PA 19105, USA, Reactive Polymers, ELSEVIER, 24,1995 99-107.
